Provectus Biopharmaceuticals, Inc. (PVCT): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

420.28M
Year ended 2025-12-31
+0.1%
3-year compound annual growth
2022-12-31: 419.47M2023-12-31: 419.51M2024-12-31: 419.81M2025-12-31: 420.28M420.28M
2022-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-31420.28M+0.1%2026-03-26, From 2025-01-01
2024-12-31419.81M+0.1%2026-03-26, From 2024-01-01
2023-12-31419.51M0.0%2025-03-28, From 2023-01-01
2022-12-31419.47Mn/a2024-03-28, From 2022-01-01